LUPRON DEPOT (leuprolide acetate for extended-release injectable suspension) is a hormonal medication first approved by Health Canada in 1989 for advanced prostate cancer, and later for various ...
Paul Hinds, a cybersecurity expert who likes yoga and bicycling, was diagnosed with prostate cancer about five years ago. He tried multiple treatments before turning to intramuscular shots of Lupron ...
The FDA is reviewing Abbott’s supplemental New Drug Application for a new six-month 45-mg formulation of Lupron Depot (leuprolide acetate for depot suspension) for the palliative treatment of advanced ...
Cipla is introducing leuprolide acetate injection depot, 22.5 mg, which is the generic of AbbVie’s Lupron Depot. It is indicated for palliative treatment of advanced prostate cancer. Leuprolide ...
Dear Dr. Roach: My husband is 89 and taking amiodarone. He had a heart attack and is taking iron infusions for anemia. He was diagnosed with prostate cancer. His PSA level is over 300 ng/mL, but his ...
"Advanced prostate cancer can have a devastating impact on patients and their quality of life," says Dr. Andrew Loblaw, Clinician Scientist and Head of Genitourinary Radiation Oncology Clinical ...
Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical. "I don't date people who don't take care ...
AbbVie announced that a new 6-month 45mg Lupron Depot (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment of advanced ...
Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical. "I don't date people who don't take care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback